Analysis of Urinary Biomarkers of Exposure to Volatile Organic Compounds from the Population Assessment of Tobacco and Health (PATH) Study (Wave 1)
Víctor R. De Jesús (1), Deepak Bhandari (1), John Ruhl (1), Nathan Geldner (1), B. Rey deCastro (1), Christopher Reese (1), Kimberly Capella (1), Alai Fernandez (1), Declan McCarthy (1), Daniel Milan (1), Cameron Movassaghi (1), Anish Patel (1), Katharine Roland (1), Denise Tevis (1), Dana van Bemmel (2), Arseima Y. Del Valle-Pinero (2), Guy Lagaud (2), Joanne Chang (2), Heather Kimmel (3), Eva Sharma (4), Maciej Goniewicz (5), Andrew Hyland (5), and Benjamin C. Blount (1) (1) Division of Laboratory Sciences, National Center for Environmental Health, U.S. Centers for Disease Control & Prevention, Atlanta, GA 30341, USA (2) Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993 USA (3) National Institutes of Health, Bethesda, MD, USA (4) Westat, 1600 Research Boulevard, Rockville, MD, 20850, USA (5) Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA
Warning: Undefined variable $headshot in /var/www/html/view_abstract/view_abstract_in_program.php on line 704
| | Victor De Jesus (Presenter)  Centers for Disease Control and Prevention |
No relevant financial relationship(s) to disclose.
|
|